About Us

We aim to maximise our impact on eye health by targeting common and rare eye conditions that lead to life-long visual impairment in young people. This will help tackle the lack of opportunities that can affect people with sight-loss throughout their lives.

We aim to develop new ways of identifying those at risk of vision loss, enabling earlier preventative treatment. This includes developing innovative techniques for assessing eye health at home and in the community, as well as in a hospital setting. We also aim to ensure vulnerable groups are not excluded, which means streamlining and developing access to eye care in a way that is fair for everyone.

We aim to build on our world-leading collections of digital data that include imaging, health records and genetics. By combining these with clinical data and basic science knowledge, and applying AI, we will gain insights into the causes of eye diseases and learn how best to prevent and treat them. Ultimately, this will allow us to tailor interventions to suit specific populations and individuals.

We aim to continue researching and discovering the normal and abnormal functioning of the eye, at a molecular, cellular and tissue level. This includes the processes of blood vessels, inflammation and the nervous system. Disturbances in these systems underlie most causes of sight loss and general diseases; greater understanding of them will lead to better diagnosis and treatment.

To continue our previous success in discovery and development of new, improved types of treatment by innovating with gene and stem-cell therapy, antibodies, laser, small molecules and novel micro-devices. Some of these regenerate ageing or damaged tissues, including stem cells. Some take only minutes to administer, and are specifically designed to treat some common eye conditions in a single treatment, with benefits lasting years.